Literature DB >> 15927637

Solution structure and thermodynamic investigation of the HIV-1 frameshift inducing element.

David W Staple1, Samuel E Butcher.   

Abstract

Expression of the HIV reverse transcriptase and other essential viral enzymes requires a -1 translational frameshift. The frameshift event is induced by two highly conserved RNA elements within the HIV-1 mRNA: a UUUUUUA heptamer known as the slippery sequence, and a downstream RNA structure. Here, we report structural and thermodynamic evidence that the HIV-1 frameshift site RNA forms a stem-loop and lower helix separated by a three-purine bulge. We have determined the structure of the 45 nucleotide frameshift site RNA using multidimensional heteronuclear nuclear magnetic resonance (NMR) methods. The upper helix is highly thermostable (T(m)>90 degrees C), forming 11 Watson-Crick base-pairs capped by a stable ACAA tetraloop. The eight base-pair lower helix was found to be only moderately stable (T(m)=47 degrees C). A three-purine bulge separates the highly stable upper helix from the lower helix. Base stacking in the bulge forms a wedge, introducing a 60 degrees bend between the helices. Interestingly, this bend is similar to those seen in a number of frameshift inducing pseudoknots for which structures have been solved. The lower helix must denature to allow the ribosome access to the slippery site, but likely functions as a positioning element that enhances frameshift efficiency.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15927637     DOI: 10.1016/j.jmb.2005.03.038

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  56 in total

Review 1.  Targeting frameshifting in the human immunodeficiency virus.

Authors:  Léa Brakier-Gingras; Johanie Charbonneau; Samuel E Butcher
Journal:  Expert Opin Ther Targets       Date:  2012-03       Impact factor: 6.902

2.  Strategies for recognition of stem-loop RNA structures by synthetic ligands: application to the HIV-1 frameshift stimulatory sequence.

Authors:  Prakash B Palde; Leslie O Ofori; Peter C Gareiss; Jaclyn Lerea; Benjamin L Miller
Journal:  J Med Chem       Date:  2010-08-26       Impact factor: 7.446

3.  Identification of a cellular factor that modulates HIV-1 programmed ribosomal frameshifting.

Authors:  Yoshifumi Kobayashi; Jianling Zhuang; Stuart Peltz; Joseph Dougherty
Journal:  J Biol Chem       Date:  2010-04-23       Impact factor: 5.157

4.  The 5' UTR of HIV-1 full-length mRNA and the Tat viral protein modulate the programmed -1 ribosomal frameshift that generates HIV-1 enzymes.

Authors:  Johanie Charbonneau; Karine Gendron; Gerardo Ferbeyre; Léa Brakier-Gingras
Journal:  RNA       Date:  2012-01-27       Impact factor: 4.942

5.  Analyzing the flexibility of RNA structures by constraint counting.

Authors:  Simone Fulle; Holger Gohlke
Journal:  Biophys J       Date:  2008-02-15       Impact factor: 4.033

6.  Predicting ribosomal frameshifting efficiency.

Authors:  Song Cao; Shi-Jie Chen
Journal:  Phys Biol       Date:  2008-03-11       Impact factor: 2.583

7.  Stability of HIV Frameshift Site RNA Correlates with Frameshift Efficiency and Decreased Virus Infectivity.

Authors:  Pablo Garcia-Miranda; Jordan T Becker; Bayleigh E Benner; Alexander Blume; Nathan M Sherer; Samuel E Butcher
Journal:  J Virol       Date:  2016-07-11       Impact factor: 5.103

8.  An RNA Element That Facilitates Programmed Ribosomal Readthrough in Turnip Crinkle Virus Adopts Multiple Conformations.

Authors:  Micki M Kuhlmann; Maitreyi Chattopadhyay; Vera A Stupina; Feng Gao; Anne E Simon
Journal:  J Virol       Date:  2016-09-12       Impact factor: 5.103

Review 9.  Mechanisms employed by retroviruses to exploit host factors for translational control of a complicated proteome.

Authors:  Cheryl Bolinger; Kathleen Boris-Lawrie
Journal:  Retrovirology       Date:  2009-01-24       Impact factor: 4.602

10.  Interaction of the HIV-1 frameshift signal with the ribosome.

Authors:  Marie-Hélène Mazauric; Yeonee Seol; Satoko Yoshizawa; Koen Visscher; Dominique Fourmy
Journal:  Nucleic Acids Res       Date:  2009-12       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.